Back to results
US 2019/0169287 A1Published application
Treatment of cancer with anti-il-1 alpha antibodies
AssigneeXbiotech, Inc.
InventorJohn Simard
Life of this patent
Estimating the term…
Abstract
Treating a patient with anti-IL-1α antibody or anti-IL-1α immunization s a cancer treatment.
Claims5
A method of reducing the formation of new metastases comprising human cancer cells in a subject harboring said human cancer cells, the method comprising a step of administering to the subject an amount of anti-human interleukin-1alpha (IL-1α) antibodies effective to reduce the development of new metastases in the subject, wherein the formation of new metastases in the lungs or liver of the subject is reduced.
Dependencies are inferred from the claim text.